These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30673073)

  • 1. Targeted Treatment of TREX1 Chilblain Lupus and Other Interferonopathies-Taming T REX.
    Damsky W; King BA
    JAMA Dermatol; 2019 Mar; 155(3):283-284. PubMed ID: 30673073
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of Clinical Response to Janus Kinase Inhibition in Patients With Familial Chilblain Lupus and TREX1 Mutation.
    Zimmermann N; Wolf C; Schwenke R; Lüth A; Schmidt F; Engel K; Lee-Kirsch MA; Günther C
    JAMA Dermatol; 2019 Mar; 155(3):342-346. PubMed ID: 30673078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A homozygote TREX1 mutation in two siblings with different phenotypes: Chilblains and cerebral vasculitis.
    Kisla Ekinci RM; Balci S; Bisgin A; Altintas DU; Yilmaz M
    Eur J Med Genet; 2017 Dec; 60(12):690-694. PubMed ID: 28919362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial chilblain lupus due to a novel mutation in the exonuclease III domain of 3' repair exonuclease 1 (TREX1).
    Günther C; Berndt N; Wolf C; Lee-Kirsch MA
    JAMA Dermatol; 2015 Apr; 151(4):426-31. PubMed ID: 25517357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial chilblain lupus due to a novel mutation in TREX1 associated with Aicardi-Goutie'res syndrome.
    Yi C; Li Q; Xiao J
    Pediatr Rheumatol Online J; 2020 Apr; 18(1):32. PubMed ID: 32293470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inherited or de novo mutation affecting aspartate 18 of TREX1 results in either familial chilblain lupus or Aicardi-Goutières syndrome.
    Tüngler V; Silver RM; Walkenhorst H; Günther C; Lee-Kirsch MA
    Br J Dermatol; 2012 Jul; 167(1):212-4. PubMed ID: 22356656
    [No Abstract]   [Full Text] [Related]  

  • 7. A TREX1 mutation causing cerebral vasculopathy in a patient with familial chilblain lupus.
    Yamashiro K; Tanaka R; Li Y; Mikasa M; Hattori N
    J Neurol; 2013 Oct; 260(10):2653-5. PubMed ID: 23989343
    [No Abstract]   [Full Text] [Related]  

  • 8. Heterozygous TREX1 p.Asp18Asn mutation can cause variable neurological symptoms in a family with Aicardi-Goutieres syndrome/familial chilblain lupus.
    Abe J; Izawa K; Nishikomori R; Awaya T; Kawai T; Yasumi T; Hiragi N; Hiragi T; Ohshima Y; Heike T
    Rheumatology (Oxford); 2013 Feb; 52(2):406-8. PubMed ID: 22829693
    [No Abstract]   [Full Text] [Related]  

  • 9. A Novel Type I Interferon Primed Dendritic Cell Subpopulation in TREX1 Mutant Chilblain Lupus Patients.
    Eugster A; Müller D; Gompf A; Reinhardt S; Lindner A; Ashton M; Zimmermann N; Beissert S; Bonifacio E; Günther C
    Front Immunol; 2022; 13():897500. PubMed ID: 35911727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of JAK1/2 inhibition in the treatment of chilblain lupus due to TREX1 deficiency.
    Briand C; Frémond ML; Bessis D; Carbasse A; Rice GI; Bondet V; Duffy D; Chatenoud L; Blanche S; Crow YJ; Neven B
    Ann Rheum Dis; 2019 Mar; 78(3):431-433. PubMed ID: 30282666
    [No Abstract]   [Full Text] [Related]  

  • 11. Human disease phenotypes associated with mutations in TREX1.
    Rice GI; Rodero MP; Crow YJ
    J Clin Immunol; 2015 Apr; 35(3):235-43. PubMed ID: 25731743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic involvement in TREX1-associated familial chilblain lupus.
    Günther C; Hillebrand M; Brunk J; Lee-Kirsch MA
    J Am Acad Dermatol; 2013 Oct; 69(4):e179-81. PubMed ID: 24034389
    [No Abstract]   [Full Text] [Related]  

  • 13. Exonuclease TREX1 degrades double-stranded DNA to prevent spontaneous lupus-like inflammatory disease.
    Grieves JL; Fye JM; Harvey S; Grayson JM; Hollis T; Perrino FW
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5117-22. PubMed ID: 25848017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulated type I IFN response in TREX1-associated familial chilblain lupus.
    Peschke K; Friebe F; Zimmermann N; Wahlicht T; Schumann T; Achleitner M; Berndt N; Luksch H; Behrendt R; Lee-Kirsch MA; Roers A; Günther C
    J Invest Dermatol; 2014 May; 134(5):1456-1459. PubMed ID: 24270665
    [No Abstract]   [Full Text] [Related]  

  • 15. Familial chilblain lupus--a monogenic form of cutaneous lupus erythematosus due to a heterozygous mutation in TREX1.
    Günther C; Meurer M; Stein A; Viehweg A; Lee-Kirsch MA
    Dermatology; 2009; 219(2):162-6. PubMed ID: 19478477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Familial chilblain lupus : Type 1 interferonopathy with model character].
    Fiehn C
    Z Rheumatol; 2017 May; 76(4):322-327. PubMed ID: 28389709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Type I interferonopathies].
    Munoz J; Marque M; Dandurand M; Meunier L; Crow YJ; Bessis D
    Ann Dermatol Venereol; 2015 Nov; 142(11):653-63. PubMed ID: 26363997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus.
    Lee-Kirsch MA; Gong M; Chowdhury D; Senenko L; Engel K; Lee YA; de Silva U; Bailey SL; Witte T; Vyse TJ; Kere J; Pfeiffer C; Harvey S; Wong A; Koskenmies S; Hummel O; Rohde K; Schmidt RE; Dominiczak AF; Gahr M; Hollis T; Perrino FW; Lieberman J; Hübner N
    Nat Genet; 2007 Sep; 39(9):1065-7. PubMed ID: 17660818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe chilblain lupus is associated with heterozygous missense mutations of catalytic amino acids or their adjacent mutations in the exonuclease domains of 3'-repair exonuclease 1.
    Sugiura K; Takeichi T; Kono M; Ito Y; Ogawa Y; Muro Y; Akiyama M
    J Invest Dermatol; 2012 Dec; 132(12):2855-7. PubMed ID: 22718116
    [No Abstract]   [Full Text] [Related]  

  • 20. Chilblain lupus erythematosus--a review of literature.
    Hedrich CM; Fiebig B; Hauck FH; Sallmann S; Hahn G; Pfeiffer C; Heubner G; Lee-Kirsch MA; Gahr M
    Clin Rheumatol; 2008 Aug; 27(8):949-54. PubMed ID: 18543054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.